Cas12a/gRNA-based platform for rapid and accurate identification of major Mycobacterium species.
Mycobacterium tuberculosis (MTB) infection and nontuberculous mycobacteria (NTM) infection exhibit similar clinical symptoms; however, the therapies for these two types of infections are different. Therefore, the rapid and accurate identification of MTB and NTM species is very important for the control of tuberculosis and NTM. In the present study, a Cas12a/gRNA-based platform was developed to identify MTB and most NTM species. By designing species-specific gRNA probes targeting the rpoB sequence, a Cas12a/gRNA-based platform successfully identified MTB and six major NTM species (Mycobacterium abscessus (MAB), Mycobacterium intracellulare (MIN), Mycobacterium avium (MAV), Mycobacterium kansasii (MKA), Mycobacterium gordonae (MGO) and Mycobacterium fortuitum (MFO)) without cross-reactivity. In a blinded manner, a total of 72 out of 73 clinical Mycobacterium isolates were correctly identified, which is consistent with previous rpoB sequencing results. These results suggest that the Cas12a/gNRA-based platform is a promising tool for the rapid, accurate and cost-effective identification of MTB and NTM species.